Kurma Partners

Kurma Partners is a leading European venture capital group specializing in healthcare, managing €470 million in assets. Our firm operates through two dedicated franchises: Kurma Biofund, which focuses on therapeutics (currently active with fund KBIII), and Kurma Diagnostics, which focuses on diagnostic and digital health (currently active with fund Kurma Dx2). We are committed to supporting innovation in healthcare by investing in promising companies that are poised to make significant advancements in therapeutic treatments and diagnostic technologies.